Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rallybio Corporaton
(NQ:
RLYB
)
1.110
+0.010 (+0.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rallybio Corporaton
< Previous
1
2
3
4
5
6
Next >
Why Is Rallybio (RLYB) Stock Up 93% Today?
April 11, 2024
Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 11, 2024
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via
InvestorPlace
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
April 11, 2024
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 10, 2024
Via
Benzinga
Rallybio: Q4 Earnings Insights
March 12, 2024
Via
Benzinga
Where Rallybio Stands With Analysts
November 29, 2023
Via
Benzinga
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
April 10, 2024
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting
April 01, 2024
From
Rallybio Corporation
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 15, 2024
Via
Benzinga
Expert Ratings for Rallybio
November 10, 2023
Via
Benzinga
Rallybio: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Where Rallybio Stands With Analysts
September 05, 2023
Via
Benzinga
Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the TD Cowen 44th Annual Health Care Conference
February 26, 2024
From
Rallybio Corporation
Via
Business Wire
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
February 07, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Rallybio Announces Portfolio Prioritization and Provides Corporate Update
February 06, 2024
From
Rallybio Corporation
Via
Business Wire
Analyst Ratings for Rallybio
August 10, 2023
Via
Benzinga
Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024
January 04, 2024
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
December 20, 2023
From
Rallybio Corporation
Via
Business Wire
Rallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65th American Society of Hematology Annual Meeting
December 09, 2023
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
November 28, 2023
From
Rallybio Corporation
Via
Business Wire
Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 09, 2023
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at Upcoming Investor Conferences in November
November 08, 2023
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual Meeting
November 02, 2023
From
Rallybio Corporation
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 05, 2023
Via
Benzinga
Rallybio to Present at the JonesTrading 2023 Healthcare Summit
October 03, 2023
From
Rallybio Corporation
Via
Business Wire
Rallybio Presents Phase 1 Single Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
September 03, 2023
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at Upcoming Investor Conferences in September
August 31, 2023
From
Rallybio Corporation
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
On Monday, 369 companies set new 52-week lows.
Via
Benzinga
Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 08, 2023
From
Rallybio Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.